Literature DB >> 30259850

Understanding and Treating Pruritus in Primary Biliary Cholangitis.

Andres F Carrion1, Jordan D Rosen2, Cynthia Levy3.   

Abstract

Pruritus is a common symptom with primary biliary cholangitis. Research has focused on refining understanding of the neurohumoral pathways involved in transduction of pruritus from peripheral cutaneous receptors to the central nervous system, and identifying modulating drugs. Current treatments have variable efficacy and safety. Because of the deleterious effects on quality of life or debilitation, many patients necessitate individualized therapeutic approaches; clinicians may need to consider invasive treatment options. This article highlights various therapeutic interventions, from general measures to invasive strategies, and novel agents under investigation, providing clinicians with the management tricks of the trade.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholestasis; Intractable; Itch; Refractory; Therapy

Mesh:

Substances:

Year:  2018        PMID: 30259850     DOI: 10.1016/j.cld.2018.03.005

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  4 in total

1.  Novel Therapies for Cholestatic Liver Disease.

Authors:  Cynthia Levy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-09

Review 2.  Skin Changes in Cirrhosis.

Authors:  Adhyatm Bhandari; Rahul Mahajan
Journal:  J Clin Exp Hepatol       Date:  2021-12-28

3.  A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease.

Authors:  Daniel Azoulay; Cyrille Feray; Chetana Lim; Chady Salloum; Maria Conticchio; Daniel Cherqui; Antonio Sa Cunha; René Adam; Eric Vibert; Didier Samuel; Marc Antoine Allard; Nicolas Golse
Journal:  JHEP Rep       Date:  2022-02-12

Review 4.  Cholestatic pruritus: a knowledge update.

Authors:  Thaís Reginatto Nietsche; Gabriel Dotta; Carlos Baptista Barcaui; Maria Lúcia Cardoso Gomes Ferraz
Journal:  An Bras Dermatol       Date:  2022-03-09       Impact factor: 2.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.